14-day Premium Trial Subscription Sign Up For FreeGet Free

Fate Therapeutics Stock Forecast NASDAQ:FATE

$54.84 (0%)

Volume: 0

Closed: Oct 29, 2021

Hollow Logo Score: -1.928

Fate Therapeutics Stock Forecast

$54.84 (0%)

Volume: 0

Closed: Oct 29, 2021

Score Hollow Logo -1.928

Fate Therapeutics Stock Price (Quote) NASDAQ:FATE

$54.84 ( 0% ) Friday, 29th Oct 2021

Range Low Price High Price Comment
30 days $54.49 $63.72 Friday, 29th Oct 2021 FATE stock ended at $54.84. During the day the stock fluctuated 0% from a day low at $54.84 to a day high of $54.84.
90 days $54.49 $97.43
52 weeks $42.64 $121.16

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2021-10-29 $54.84 $54.84 $54.84 $54.84 0
2021-10-27 $59.05 $60.10 $54.83 $54.84 1 238 346
2021-10-26 $58.31 $60.60 $57.50 $59.31 2 400 869
2021-10-25 $58.91 $59.77 $57.17 $58.16 1 368 503
2021-10-22 $59.40 $59.50 $58.10 $59.00 689 408
2021-10-21 $60.16 $61.26 $59.01 $59.48 790 245
2021-10-20 $60.89 $61.91 $59.41 $59.57 638 214
2021-10-19 $60.63 $63.23 $60.12 $61.17 1 340 388
2021-10-18 $60.71 $61.61 $59.79 $60.11 590 862
2021-10-15 $63.62 $63.72 $60.97 $61.24 807 868
2021-10-14 $61.00 $63.37 $60.79 $62.51 697 171
2021-10-13 $59.34 $60.60 $58.69 $60.15 901 165
2021-10-12 $57.11 $59.25 $56.84 $59.07 837 166
2021-10-11 $54.93 $56.99 $54.49 $56.55 720 912
2021-10-08 $56.94 $58.32 $54.57 $54.93 861 056
2021-10-07 $57.51 $58.97 $56.18 $56.33 795 571
2021-10-06 $56.37 $57.64 $54.88 $57.12 874 117
2021-10-05 $57.01 $57.54 $55.06 $57.30 953 788
2021-10-04 $58.78 $58.78 $55.19 $56.41 1 213 350
2021-10-01 $59.66 $60.47 $57.22 $59.50 961 961
2021-09-30 $60.13 $60.74 $58.92 $59.27 1 122 694
2021-09-29 $61.66 $62.80 $58.92 $59.80 866 867
2021-09-28 $62.53 $63.05 $59.92 $60.79 1 252 734
2021-09-27 $64.73 $65.39 $62.35 $64.36 905 780
2021-09-24 $68.30 $68.63 $64.41 $64.85 1 098 845
2021-09-23 $69.79 $70.29 $67.28 $68.86 831 050
2021-09-22 $68.24 $69.72 $67.67 $68.89 464 817
2021-09-21 $67.68 $70.94 $67.03 $68.13 530 444
2021-09-20 $68.38 $70.39 $66.90 $67.20 1 122 259
2021-09-17 $67.14 $72.29 $65.60 $71.60 2 060 373
2021-09-16 $66.23 $67.16 $64.67 $66.51 481 342
2021-09-15 $64.63 $66.83 $64.11 $66.50 713 278
2021-09-14 $66.03 $67.11 $64.09 $64.81 767 876
2021-09-13 $69.51 $69.51 $65.20 $65.78 1 026 003
2021-09-10 $70.11 $70.50 $67.73 $68.43 706 039
2021-09-09 $69.21 $72.67 $68.62 $69.32 957 239
2021-09-08 $73.00 $74.35 $69.39 $69.52 938 570
2021-09-07 $73.10 $75.79 $72.63 $73.16 1 983 282
2021-09-03 $75.31 $75.73 $72.11 $72.98 926 041
2021-09-02 $76.10 $76.42 $74.60 $75.50 721 013
2021-09-01 $73.46 $76.35 $73.46 $75.30 910 684
2021-08-31 $71.81 $73.38 $71.07 $73.25 620 235
2021-08-30 $73.00 $74.69 $71.62 $71.74 709 748
2021-08-27 $71.64 $73.95 $71.00 $72.64 1 089 809
2021-08-26 $72.40 $74.02 $70.10 $71.25 722 482
2021-08-25 $71.56 $73.82 $70.53 $72.94 745 283
2021-08-24 $72.31 $72.89 $69.70 $71.53 1 780 616
2021-08-23 $67.67 $72.29 $67.56 $72.27 2 908 683
2021-08-20 $72.61 $73.00 $66.76 $67.01 6 448 405
2021-08-19 $89.26 $90.61 $85.05 $85.63 1 460 836

About Fate Therapeutics

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops programmed cellular immunotherapies for cancer and immune disorders in the United States. Its novel ex vivo cell programming approach applies to modulate the therapeutic function and direct the fate of immune cells. The company’s lead product candidate is ProTmune, a programmed immuno-regulatory cell therapy that is in clinical development stage for the p... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT